Tracy P B, Giles A R, Mann K G, Eide L L, Hoogendoorn H, Rivard G E
J Clin Invest. 1984 Oct;74(4):1221-8. doi: 10.1172/JCI111531.
Studies were performed on a French-Canadian family afflicted with a bleeding disorder exhibiting an autosomal dominant inheritance pattern and a severe bleeding diathesis after trauma. Clinical laboratory coagulation tests were unimpressive; the only persistent abnormalities include mild thrombocytopenia and moderately reduced Factor V clotting activities. Some individuals had prolonged Stypven times when platelet-rich plasma was used, suggesting that their platelets could not support functional prothrombinase complex assembly. Detailed studies were performed by use of plasma and isolated, washed platelets from a sister and brother. Bioassay data indicate that both individuals had Factor V activities of approximately 40 and 36% of normal, respectively. A comparison of the Factor V radioimmunoassay and bioassay data on the brother's plasma indicated that the circulating amount of Factor V functional activity was low relative to Factor V antigen concentration (approximately 65-75%). In both individuals, the platelet Factor V functional activities were extremely low (2-4%) relative to antigen levels present as determined by radioimmunoassay. These discrepancies between Factor V activities and antigen concentration do not appear to be due to an unstable Factor V molecule or to the presence of a Factor V or Factor Va inhibitor or inactivator. Kinetics of prothrombin activation by use of purified clotting factors indicated that thrombin-activated platelets from both individuals supported prothrombinase complex assembly identical to controls in the presence of added purified Factor Va. Consequently, their bleeding diathesis appears to reflect their platelet, rather than their plasma, Factor V activity. These results suggest that platelet Factor V is an essential component in maintaining stable and prolonged hemostasis after trauma.
对一个法裔加拿大家庭进行了研究,该家庭患有一种出血性疾病,呈现常染色体显性遗传模式,创伤后有严重的出血素质。临床实验室凝血试验结果不显著;唯一持续存在的异常包括轻度血小板减少和因子V凝血活性中度降低。当使用富含血小板的血浆时,一些个体的蝰蛇毒时间延长,这表明他们的血小板无法支持功能性凝血酶原酶复合物的组装。利用一名姐妹和兄弟的血浆以及分离、洗涤后的血小板进行了详细研究。生物测定数据表明,这两名个体的因子V活性分别约为正常水平的40%和36%。对该兄弟血浆中因子V放射免疫测定和生物测定数据的比较表明,相对于因子V抗原浓度,循环中的因子V功能活性较低(约65 - 75%)。在这两名个体中,相对于放射免疫测定确定的抗原水平,血小板因子V功能活性极低(2 - 4%)。因子V活性与抗原浓度之间的这些差异似乎并非由于因子V分子不稳定,也不是由于存在因子V或因子Va抑制剂或灭活剂。使用纯化的凝血因子进行凝血酶原激活动力学研究表明,在添加纯化的因子Va的情况下,来自这两名个体的凝血酶激活血小板支持与对照相同的凝血酶原酶复合物组装。因此,他们的出血素质似乎反映了其血小板而非血浆中的因子V活性。这些结果表明,血小板因子V是创伤后维持稳定和持久止血的重要组成部分。